Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 74,370,040
  • Shares Outstanding, K 451,165
  • Annual Sales, $ 8,544 M
  • Annual Income, $ 2,344 M
  • EBIT $ 3,195 M
  • EBITDA $ 3,686 M
  • 60-Month Beta 0.89
  • Price/Sales 8.63
  • Price/Cash Flow 25.47
  • Price/Book 14.15

Options Overview Details

View History
  • Implied Volatility 24.54% ( -3.55%)
  • Historical Volatility 18.21%
  • IV Percentile 50%
  • IV Rank 18.03%
  • IV High 46.29% on 08/05/24
  • IV Low 19.76% on 08/16/24
  • Put/Call Vol Ratio 2.90
  • Today's Volume 5,646
  • Volume Avg (30-Day) 1,289
  • Put/Call OI Ratio 1.11
  • Today's Open Interest 32,734
  • Open Int (30-Day) 26,146

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.38
  • Number of Estimates 9
  • High Estimate 1.44
  • Low Estimate 1.36
  • Prior Year 1.24
  • Growth Rate Est. (year over year) +11.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.37 +0.90%
on 12/19/24
181.85 -9.35%
on 12/13/24
-10.83 (-6.16%)
since 11/20/24
3-Month
163.37 +0.90%
on 12/19/24
197.51 -16.54%
on 09/27/24
-27.80 (-14.43%)
since 09/20/24
52-Week
144.80 +13.84%
on 04/22/24
200.53 -17.80%
on 02/29/24
-29.79 (-15.31%)
since 12/20/23

Most Recent Stories

More News
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income

If you're an investor looking to grow your long-term passive income prospects, the five stocks in this article could be perfect to add to your portfolio before 2025.

MDLZ : 59.39 (+0.20%)
VZ : 39.93 (-0.10%)
AMT : 183.73 (+2.41%)
HSY : 170.26 (+0.78%)
TMUS : 220.31 (+1.06%)
TWR.AX : 1.192 (+1.02%)
T : 22.75 (+0.80%)
MTYFF : 32.2700 (-0.34%)
MCO : 466.35 (+0.92%)
ZTS : 164.84 (+0.81%)
SPGI : 491.81 (+1.08%)
PSA : 297.50 (+2.82%)
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025

One of my favorite ways to add money to my portfolio is to invest in proven compounders with track records of delivering market-beating results after short-term pullbacks. This idea is especially true...

ZTS : 164.84 (+0.81%)
IDXX : 412.26 (+0.79%)
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has recently underperformed the broader healthcare sector, but analysts remain optimistic about its long-term growth prospects.

XLV : 138.00 (+1.26%)
ELAN : 11.63 (-1.61%)
ZTS : 164.84 (+0.81%)
Insider Sale: Executive Vice President of $ZTS (ZTS) Sells 3,477 Shares

Robert J Polzer, the Executive Vice President of $ZTS ($ZTS), sold 3,477 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 51.7%...

ZTS : 164.84 (+0.81%)
3 'Strong Buy' Cyclical Stocks to Scoop Up Now

Brokerage firm Morgan Stanley is bullish on cyclical stocks.

MA : 528.03 (+0.91%)
ZTS : 164.84 (+0.81%)
SLB : 36.83 (-0.22%)
Can Emerging Agritech and Biotech Solutions Meet the World’s Food Security Demands?

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Reception to recent US election results has been mixed within the agriculture sector, with enthusiasm from some and...

CALM : 102.89 (-1.42%)
BVAXF : 0.0475 (+2.15%)
CTVA : 57.48 (+2.35%)
ELAN : 11.63 (-1.61%)
BIOV.CN : 0.0650 (+8.33%)
ZTS : 164.84 (+0.81%)
What Are Wall Street Analysts' Target Price for Zoetis Stock?

Zoetis has significantly underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.

XPH : 43.42 (+0.39%)
$SPX : 5,930.85 (+1.09%)
JPM : 237.60 (+1.99%)
ZTS : 164.84 (+0.81%)
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback

Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip.

ZTS : 164.84 (+0.81%)
PFE : 26.36 (+2.29%)
Zoetis (ZTS) Q3 2024 Earnings Call Transcript

ZTS earnings call for the period ending September 30, 2024.

ZTS : 164.84 (+0.81%)
Zoetis: Q3 Earnings Snapshot

Zoetis: Q3 Earnings Snapshot

ZTS : 164.84 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 169.17
2nd Resistance Point 167.78
1st Resistance Point 166.31
Last Price 164.84
1st Support Level 163.45
2nd Support Level 162.06
3rd Support Level 160.59

See More

52-Week High 200.53
Fibonacci 61.8% 179.24
Fibonacci 50% 172.67
Fibonacci 38.2% 166.09
Last Price 164.84
52-Week Low 144.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar